COMINDUS FINANCE CORP. 4
4 · KYTO BIOPHARMA INC · Filed Jun 7, 2018
Insider Transaction Report
Form 4
Credifinance Capital Corp.
10% Owner
Transactions
- Other
Warrant
2018-04-25+400,000→ 400,000 totalExercise: $1.20From: 2018-04-25Exp: 2021-04-25→ Common (333,333 underlying) - Other
Class B Preferred Shares
2018-04-25$0.80/sh+400,000$320,000→ 400,000 total
Footnotes (1)
- [F1]Conversion of debt totalling $320,000 owed by Issuer to Reporting Company - Comindus Finance Corp. - into 400,000 Preferred Units at $0.80 per Unit - each Unit consisting of 1 Class B Preferred Share and 1 Warrant exercisable into 1 common share at $1.20 to 25/04/2021